Menu

Image of the Day: Flushing the Gut

In response to a bacterial infection, an immune signal in mice's guts triggers a molecular cascade that promotes diarrhea, which, researchers demonstrate, is important for ridding them of the bacteria.  

Jun 19, 2017
The Scientist Staff

An immunofluorescence microscopy image depicts the intestinal lumen of a mouse lacking claudin-2, a diarrhea-inducing tight junction protein. In these deficient mice, C. rodentium bacteria (red) infiltrate the intestines. DNA stained in blue; F-actin (denoting cells' external-facing surfaces) in green.

TURNER LABORATORY AT BRIGHAM AND WOMEN’S HOSPITAL

           Scientists investigating the functional role of diarrhea found that bacterial pathogens stimulate the immune signaling protein IL-22, which increases claudin-2 expression and facilitates the outflow of water and subsequently, diarrhea. According to a news release, this “play[s] a critical role in pathogen clearance in the early stages of infection.”

See P.-Y. Tsai et al., “IL-22 upregulates epithelial claudin-2 to drive diarrhea and enteric pathogen clearance,” Cell Host & Microbe, doi:10.1016/j.chom.2017.05.009, 2017.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.